188 related articles for article (PubMed ID: 33052095)
1. [Unleashing NK cell signaling to improve cancer immunotherapy].
Bernard PL; Laletin V; Pastor S; Nunès JA; Guittard G
Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():50-55. PubMed ID: 33052095
[No Abstract] [Full Text] [Related]
2. [TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
Foughali R; Marie JC
Med Sci (Paris); 2020 Jan; 36(1):77-79. PubMed ID: 32014103
[No Abstract] [Full Text] [Related]
3. [New frontiers in the fight against cancer].
Chiossone L; Vivier E
Biol Aujourdhui; 2018; 212(3-4):61-67. PubMed ID: 30973133
[TBL] [Abstract][Full Text] [Related]
4. [Natural killer cells: promising targets in cancer therapy].
Cornen S; André P; Gauthier L; Morel Y; Vivier É
Med Sci (Paris); 2019 Dec; 35(12):990-992. PubMed ID: 31903904
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.
Bugide S; Janostiak R; Wajapeyee N
Trends Cancer; 2018 Aug; 4(8):553-566. PubMed ID: 30064663
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells and anti-tumor immunity.
Nicholson SE; Keating N; Belz GT
Mol Immunol; 2019 Jun; 110():40-47. PubMed ID: 29233542
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy and targeted therapy, a promising combination to fight cancer].
Andrieu N; Bendriss-Vermare N
Med Sci (Paris); 2018 Oct; 34(10):872-875. PubMed ID: 30451657
[No Abstract] [Full Text] [Related]
8. Pharmacological targeting of natural killer cells for cancer immunotherapy.
Miyazato K; Hayakawa Y
Cancer Sci; 2020 Jun; 111(6):1869-1875. PubMed ID: 32301190
[TBL] [Abstract][Full Text] [Related]
9. [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response].
Gros L; Paturel C; Perrot I; Bensussan A; Eliaou JF; Bastid J; Bonnefoy N
Med Sci (Paris); 2020 Feb; 36(2):112-115. PubMed ID: 32129745
[No Abstract] [Full Text] [Related]
10. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic antibodies: Discovery, design and deployment.
Ramsland PA; Hutchinson AT; Carter PJ
Mol Immunol; 2015 Oct; 67(2 Pt A):1-3. PubMed ID: 25990602
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell receptors: alterations and therapeutic targeting in malignancies.
Konjević G; Vuletić A; Mirjačić Martinović K
Immunol Res; 2016 Feb; 64(1):25-35. PubMed ID: 26374324
[TBL] [Abstract][Full Text] [Related]
13. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
14. First-in-class cancer therapeutic to stimulate natural killer cells.
Sheridan C
Nat Biotechnol; 2006 Jun; 24(6):597. PubMed ID: 16763573
[No Abstract] [Full Text] [Related]
15. Immunotherapy Advances: 2019.
Saleh N
Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661150
[TBL] [Abstract][Full Text] [Related]
16. Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Abel AM; Yang C; Thakar MS; Malarkannan S
Front Immunol; 2018; 9():1869. PubMed ID: 30150991
[TBL] [Abstract][Full Text] [Related]
17. Advances in Cancer Therapy: Immunotherapies.
Marmé D
Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772
[No Abstract] [Full Text] [Related]
18. First person: Arlene Sharpe, MD, PhD: Scientist's work on PD-1 pathway paves the road to key cancer immunotherapies.
Printz C
Cancer; 2018 Oct; 124(19):3795-3796. PubMed ID: 30412303
[No Abstract] [Full Text] [Related]
19. Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens.
Childs RW; Carlsten M
Nat Rev Drug Discov; 2015 Jul; 14(7):487-98. PubMed ID: 26000725
[TBL] [Abstract][Full Text] [Related]
20. The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy.
Souza-Fonseca-Guimaraes F; Cursons J; Huntington ND
Trends Immunol; 2019 Feb; 40(2):142-158. PubMed ID: 30639050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
